The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical CancerSophie Otter, Agnieszka Michael, Jayanta Chatterjee et al.|Clinical Oncology|2019Cited by 81
COVID-19 and gynecological cancer: a review of the published guidelinesChristina Uwins, Agnieszka Michael, Geetu Bhandoria et al.|International Journal of Gynecological Cancer|2020Cited by 56
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Shaharyar M. Khan, R. Muirhead et al.|The Lancet Oncology|2025Cited by 23
Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer CentreChristina Uwins, Simon Butler‐Manuel, Radwa Hablase et al.|Cancers|2022Cited by 8
Endometrial Cancer: Analysing Patterns of Recurrence and Real-Life Outcome Data Using the 2020 ESGO-ESTRO-ESP Risk Stratification SystemRebecca Karkia, Jayanta Chatterjee, Tamari Nyakunengwa et al.|Clinical Oncology|2024Cited by 7